Advances in Therapeutic Contact Lenses for the Management of Different Ocular Conditions
Journal of Personalized Medicine · 03.11.2023 · 13 (11) · 1571
DOI: 10.3390/jpm13111571 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 03.11.2023. Verfasst von Mariana Ioniță und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical Engineering, University Politehnica of Bucharest, 011061 Bucharest, Romania; georgian.toader3007@upb.ro. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Education, Scholarships, Apprenticeships And Youth Entrepreneurship Programme in Romania.
Abstract (Originalsprache)
In the advent of an increasingly aging population and due to the popularity of electronic devices, ocular conditions have become more prevalent. In the world of medicine, accomplishing eye medication administration has always been a difficult task. Despite the fact that there are many commercial eye drops, most of them have important limitations, due to quick clearance mechanisms and ocular barrers. One solution with tremendous potential is the contact lens used as a medication delivery vehicle to bypass this constraint. Therapeutic contact lenses for ocular medication delivery have attracted a lot of attention because they have the potential to improve ocular bioavailability and patient compliance, both with minimal side effects. However, it is essential not to compromise essential features such as water content, optical transparency, and modulus to attain positive in vitro and in vivo outcomes with respect to a sustained drug delivery profile from impregnated contact lenses. Aside from difficulties like drug stability and burst release, the changing of lens physico-chemical features caused by therapeutic or non-therapeutic components can limit the commercialization potential of pharmaceutical-loaded lenses. Research has progressed towards bioinspired techniques and smart materials, to improve the efficacy of drug-eluting contact lenses. The bioinspired method uses polymeric materials, and a specialized molecule-recognition technique called molecular imprinting or a stimuli–responsive system to improve biocompatibility and support the drug delivery efficacy of drug-eluting contact lenses. This review encompasses strategies of material design, lens manufacturing and drug impregnation under the current auspices of ophthalmic therapies and projects an outlook onto future opportunities in the field of eye condition management by means of an active principle-eluting contact lens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medical Engineering, University Politehnica of Bucharest, 011061 Bucharest, Romania; georgian.toader3007@upb.ro.
- Advanced Polymer Materials Group, University Politehnica of Bucharest, 011061 Bucharest, Romania.
- ebio-Hub Research Centre, University Politehnica of Bucharest-Campus, 061344 Bucharest, Romania.
- Department of Prosthetics and Dental Materials, Faculty of Dentistry, University of Medicine and Pharmacy "Iuliu Hatieganu", 400012 Cluj-Napoca, Romania.
ORCID-Profile: George Mihail Vlăsceanu
Förderung
- The Education, Scholarships, Apprenticeships And Youth Entrepreneurship Programme in Romania
Zitieren
APA
Ioniță, M., Vlăsceanu, G. M., Toader, A. G., & Manole, M. (2023). Advances in Therapeutic Contact Lenses for the Management of Different Ocular Conditions. Journal of Personalized Medicine, 13(11), 1571. https://doi.org/10.3390/jpm13111571
Vancouver
Ioniță M, Vlăsceanu GM, Toader AG, Manole M. Advances in Therapeutic Contact Lenses for the Management of Different Ocular Conditions. Journal of Personalized Medicine. 2023;13(11):1571. doi:10.3390/jpm13111571
BibTeX
@article{Ioni2023,
author = {Ioniță, Mariana and Vlăsceanu, George Mihail and Toader, Alin Georgian and Manole, Marius},
title = {Advances in Therapeutic Contact Lenses for the Management of Different Ocular Conditions},
journal = {Journal of Personalized Medicine},
year = {2023},
volume = {13},
number = {11},
pages = {1571},
doi = {10.3390/jpm13111571}
}
EUVIMED